Abstract:Leprosy is a chronic infectious disease, caused by Mycobacterium leprae, which affects skin and peripheral nerves. Polymorphisms in genes associated with autophagy, metabolism, innate and adaptive immunity confer susceptibility to leprosy. However, these associations need to be confirmed through independent replication studies in different ethnicities. The population from Amazon state (northern Brazil) is admixed and it contains the highest proportion of Native American genetic ancestry in Brazil. We conducted a case-control study for leprosy in which we tested fourteen previously associated SNPs in key immune response regulating genes: TLR1 (rs4833095), NOD2 (rs751271, rs8057341), TNF (rs1800629), IL10 (rs1800871), CCDC122/LACC1 (rs4942254), PACRG/PRKN (rs9356058, rs1040079), IFNG (rs2430561), IL6 (rs2069845), LRRK2 (rs7298930, rs3761863), IL23R (rs76418789) and TYK2 (rs55882956). Genotyping was carried out by allelic discrimination in 967 controls and 412 leprosy patients. Association with susceptibility was assessed by logistic regression analyses adjusted for the following covariates: gender, age and ancestry. Genetic ancestry was similar in case and control groups. Statistically significant results were only found for IFNG and NOD2. The rs8057341 polymorphism within NOD2 was identified as significant for the AA genotype (OR = 0.56; 95% CI, 0.37–0.84; P = 0.005) and borderline for the A allele (OR = 0.76; 95% CI, 0.58–1.00; P = 0.053) and carrier (OR = 0.76; 95% CI, 0.58–1.00; P = 0.051). The rs2430561 SNP in IFNG was associated with disease susceptibility for the AT genotype (OR = 1.40; 95% CI, 1.06–1.85; P = 0.018) and carrier (OR = 1.44; 95% CI, 1.10–1.88; P = 0.008). We confirmed that NOD2 and IFNG are major players in immunity against M.leprae in the Amazon ethnic admixed population.Leprosy is chronic infectious diseases caused by Mycobacterium leprae that affect the skin and peripheral nerves. The incidence is still high where approximately 200,000 new cases are diagnosed each year. There is no clear sign for early diagnosis and transmission is likely to occur before treatment, which, irrespective of its success, has not hampered stationary incidence in the past 20 years. Thus, there is pressing need for markers that discriminate exposure, infection and disease in order to better detect leprosy progression, control transmission and prevent disabilities. Here, we investigated whether polymorphisms located in eleven genes are associated to leprosy in a population from Amazon state (northern Brazil) which is admixed and it contains the highest proportion of Native American genetic ancestry in Brazil. We validated NOD2 and IFNG associations with resistance and risk of leprosy, respectively, in the Amazon ethnic admixed population. Genetic patterns of leprosy susceptibility could have an impact on the prognosis of individuals that are more likely to develop the disease (among household contacts, for example). Therefore, this strategy could identify high-risk individuals prone for prophylactic measures such as treatment with single-dose rifampicin and BCG vaccination.

Single nucleotide polymorphisms of the genes IL-2, IL-2RB, and JAK3 in patients with cutaneous leishmaniasis caused by Leishmania (V.) guyanensis in Manaus, Amazonas, Brazil

The association of serum level and polymorphisms of IFN-γ (rs2069705) with the susceptibility to cutaneous leishmaniasis

TREM1 rs2234237 (Thr25Ser) Polymorphism in Patients with Cutaneous Leishmaniasis Caused by Leishmania guyanensis: A Case-Control Study in the State of Amazonas, Brazil

Susceptibility to leishmaniasis is affected by host SLC11A1 gene polymorphisms: a systematic review and meta-analysis

Caspase-1 Variants and Plasma IL-1β in Patients with Leishmania guyanensis Cutaneous Leishmaniasis in the Amazonas

Human visceral leishmaniasis and polymorphisms in interleukin-coding genes: a systematic review

Association of NOD2 and IFNG single nucleotide polymorphisms with leprosy in the Amazon ethnic admixed population

Genetic variation in Interleukin-32 influence the immune response against New World Leishmania species and susceptibility to American Tegumentary Leishmaniasis

Cytokines signatures and susceptibility to cutaneous leishmaniasis in patients from Sistan and Baluchestan Province of Iran

Genetic variation of FcγRIIa induces higher uptake of Leishmania infantum and modulates cytokine production by adherent mononuclear cells in vitro

The contrasting phenotypes of neutrophils during asymptomatic versus symptomatic Leishmania braziliensis infection

Intralesional gene expression profile of JAK-STAT signaling pathway and associated cytokines in Leishmania tropica- infected patients

Prokaryotic and eukaryotic skin microbiota modifications triggered by Leishmania infection in localized Cutaneous Leishmaniasis

In Situ versus Systemic Immune Response in the Pathogenesis of Cutaneous Leishmaniasis

Analysis of clinical cure outcome, macrophages number, cytokines levels and expression of annexin-A1 in the cutaneous infection in patients with Leishmania braziliensis

Leishmania spp. genetic factors associated with cutaneous leishmaniasis antimony pentavalent drug resistance: a systematic review

AMERICAN CUTANEOUS LEISHMANIASIS WITH UNUSUAL CLINICAL PRESENTATION AND RESPONSE TO TREATMENT

Genome-wide association study analysis of single nucleotide variants in L. infantum associated with IL-6 inflammatory response in visceral leishmaniasis

Parasite genetic variation and systemic immune responses are not associated with different clinical presentations of cutaneous leishmaniasis caused by

Investigation of parasite genetic variation and systemic immune responses in patients presenting with different clinical presentations of cutaneous leishmaniasis caused by Leishmania aethiopica

Association of CC-Chemokine Ligand-2 gene Polymorphisms with Leprosy Reactions